Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

It’s time for doctors to say no to drugs

James C. Salwitz, MD
Meds
May 22, 2014
Share
Tweet
Share

The United States of America is addicted to narcotics.  I do not mean the millions of individuals who are hooked.  I mean the whole nation is jonesing for the stuff.  I also do not mean the junk that slips into our nation in coffee cans or across midnight borders.  I mean the billions of pills pouring off assembly lines.  I could blame pharma or the FDA, but the truth is closer to home.  The villains are those men and women who write prescriptions.  It is time for doctors to say no to drugs.

Now let me be clear.  I know pain.  More exactly, I know the treatment for pain.  I have fought with my cancer patients against an oppressive ocean of agony for 30 years.  I know which drugs work, when to use them and when they will fail.  I believe that pain for a cancer patient cuts deep to the soul and is a constant reminder of sickness and death.  Every patient needs access to an aggressive array of pain medications, which must include appropriate narcotics.  But come on now, things are completely out of control.

In order to treat serious pain very well takes only a few narcotics. You need a short acting pill or liquid, a long acting pill, a topically absorbed medicine, and an IV medicine.  It is a good idea to have one or two extras for allergies or reactions.  Almost all pain can be treated with some form of morphine and perhaps a little fentanyl.  High quality pain control can be achieved with less then 10 medicines.  Nevertheless, the pharmaceutical plants shower a rainbow of me-too drugs, flooding the market with deadly compounds.  Physicians fall right in line and write prescriptions for every new shiny tablet.

Here is a partial list: Actiq, Anexsia, Avinza, Bicodone, Buprenorphine, Butorphanol, Codeine, Damason-P, Darvocet, Darvon, Demerol, Di-Gesic, Dilaudid, Duodin, Duragesic, Duramorph, Embeda, Exalgo, Fentanyl, Fioricet, Fiorinal, Hycodan, Hydrococet, Hydrocodone, Hydromorphone, Kadian, Kapanol, Lorcet, MS Contin, MSIR, Meperidine,Methadone, morphine, Norco,  Nucynta ER, Opana ER, Oramorph, Orlaam, Oxycontin, Oxycodone, Percocet, Roxanol, Roxicodone, Ryzolt, Tramadol, Tramal, Tylox, Ultram, Vicodin, Vicoprofen, Xodol, Zydone,  and the newest and perhaps most controversial narcotic pain medication yet, sold in an easily abused capsule, Zohydro.  You may notice that sometimes I list both the brand name and generic … because they are both available just to add to the confusion and abuse potential.

I could blame the FDA for approving over 50 prescription narcotics when we only need a few.  However, the mandate of the agency does not allow it to consider the health of the nation as a whole.  Rather, hampered by politics, poor funding and a belief that it is just a tunnel to the consumer, the FDA views only narrow safety and efficacy concerns of individual products and takes little consideration for their affect in the real world.

I would love to blame pharma.  Why not — they are getting rich on the chaos.  However, the drug industry is burdened with the bizarre philosophy that market forces and competition is the best path to a quality care, even if it leaves a few hundred thousand bodies lying around.  Despite the blatant failure of U.S. brand capitalism to produce a healthy society, we still act as if profit and sales success equals quality.

In addition, I cannot blame patients. They are the ones in fear.  They are the ones who suffer.  We cannot say to millions of cancer patients and others who experience levels of pain beyond the wildest Kafkaesque nightmare, that they should push back and refuse the “best and newest” pain-relieving solution. That would suggests a coldness and cruelty, which I do not feel, and our society fortunately does not share.

Therefore, I blame doctors.  They should know better. They continue a humiliating history of responding to marketing instead of medical data.  Rather than use research and scientific principals to conservatively choose basic drugs and techniques that work, they kowtow to biased analysis, the easiest, the most expensive, and the latest Madison Avenue craze.  In doing so they encourage the expensive manufacturing of unnecessary products and flood our society with so many different chemicals and compounds that no one can understand the affects and our society’s health is undermined.

Doctors have always had the power of the medical order.  Nothing happens in health care unless somewhere, directly or indirectly, a doctor orders it.  Their failure to take a stand, to force medicine to be data-driven and view not only the patient on the table in front of them, but society as a whole, continues to lead us to disaster.  The misuse of narcotics threatens not only those addicted and overdosed, but the rebound deprives suffering patients of desperately needed help.

It is time for doctors to insist on the strictest standards for our patients and nation; the manufacture of medicines we truly need and outcomes based care.  It is time for doctors to say no.

James C. Salwitz is an oncologist who blogs at Sunrise Rounds.

Prev

An $8,000 hospital bill added to my already growing debt

May 21, 2014 Kevin 26
…
Next

Psychiatric hospitals need meaningful use incentives

May 22, 2014 Kevin 4
…

Tagged as: Medications, Oncology/Hematology

Post navigation

< Previous Post
An $8,000 hospital bill added to my already growing debt
Next Post >
Psychiatric hospitals need meaningful use incentives

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by James C. Salwitz, MD

  • Each line on the radiology list is a patient’s line in the sand

    James C. Salwitz, MD
  • The broader mission for hospice care

    James C. Salwitz, MD
  • Is the medical profession at its end?

    James C. Salwitz, MD

More in Meds

  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 26 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

It’s time for doctors to say no to drugs
26 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...